Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

NCT00165191 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of Stomach
Adenocarcinoma of GE Junction
Adenocarcinoma of Esophagus

Interventions

DRUG: Doxorubicin
DRUG: Cisplatin
DRUG: 5-fluorouracil

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]